日本骨科生物製品市场报告（按产品、类型、应用、最终用户和地区）2025 年至 2033 年

2024年，日本骨科生物製剂市场规模达2.835亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到5.082亿美元，2025-2033年期间的复合年增长率（CAGR）为6.2%。日益增长的老龄化人口是推动市场发展的主要因素。由于久坐不动的生活方式和肥胖等因素，老龄化人口更容易患骨关节炎和骨折等骨科疾病。

骨科生物製剂是医学的一个领域，专注于利用天然物质和生物材料来增强人体自身的癒合过程，特别是在骨科和肌肉骨骼疾病领域。这些疗法旨在刺激组织修復和再生，减少对更具侵入性的外科手术的需求，并可能改善患者的预后。常见的骨科生物製剂包括富血小板血浆 (PRP)，该疗法透过浓缩并注射患者自身的血小板来促进组织癒合；以及干细胞疗法，该疗法利用患者自身或捐赠者的干细胞来促进组织再生。此外，还有一些产品，例如骨移植和合成材料，可以模拟天然骨骼的特性，以支持骨折癒合和脊椎融合。骨科生物製剂代表了骨科领域一个充满希望的研究和治疗领域，它有可能加速各种肌肉骨骼疾病（例如关节炎、肌腱损伤和骨折）患者的康復、减轻疼痛并改善整体功能。

日本骨科生物製剂市场趋势：

日本的骨科生物製品市场正经历强劲成长，这主要得益于一系列因素，这些因素凸显了其光明的前景。首先，人口老化极大地促进了市场的扩张。随着年龄的增长，骨关节炎和骨折等肌肉骨骼疾病的发生率不断上升，因此需要透过骨科生物製品治疗来促进组织再生和修復。因此，老年人口的成长是市场成长的重要驱动力。此外，技术进步在推动骨科生物製品市场发展方面发挥了关键作用。生物技术和再生医学的创新促进了更先进、更有效的骨科生物製品产品的开发。这包括干细胞疗法、富血小板血浆 (PRP) 疗法和基于生长因子的解决方案的出现，所有这些疗法都能改善患者的治疗效果，从而推动对这些尖端疗法的需求。此外，新兴的微创手术应用可提供更快的恢復时间、更少的疼痛和更少的併发症，预计将在预测期内推动日本骨科生物学市场的发展。

日本骨科生物学市场细分：

产品洞察：

• 去矿骨基质
• 同种异体移植
• 骨形态发生蛋白
• 黏液补充产品
• 合成骨替代品
• 其他的

类型洞察：

• 膝盖
• 踝
• 时髦的
• 腕部和肩部
• 脊椎
• 其他的

应用程式洞察：

• 骨关节炎和退化性关节炎
• 脊椎融合
• 骨折恢復
• 软组织损伤
• 颚面和牙科应用

最终用户洞察：

• 医院及门诊中心
• 研究与学术机构
• 牙科诊所和设施
• 骨科诊所

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本骨科生物製剂市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本骨科生物製剂市场有何影响？
• 日本骨科生物製剂市场依产品划分是怎样的？
• 日本骨科生物製剂市场按类型划分是怎样的？
• 日本骨科生物製剂市场根据应用如何划分？
• 根据最终用户，日本骨科生物製剂市场是如何分類的？
• 日本骨生物学市场的价值链分为哪些阶段？
• 日本骨生物学领域的主要驱动因素和挑战是什么？
• 日本骨生物学市场的结构是怎么样的？主要参与者是谁？
• 日本骨生物製剂市场的竞争程度如何？

本报告回答的关键问题：

• 日本骨科生物製剂市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本骨科生物製剂市场有何影响？
• 日本骨科生物製剂市场依产品划分是怎样的？
• 日本骨科生物製剂市场按类型划分是怎样的？
• 日本骨科生物製剂市场根据应用如何划分？
• 根据最终用户，日本骨科生物製剂市场是如何分類的？
• 日本骨生物学市场的价值链分为哪些阶段？
• 日本骨生物学领域的主要驱动因素和挑战是什么？
• 日本骨生物学市场的结构是怎么样的？主要参与者是谁？
• 日本骨生物製剂市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本骨科生物製品市场－简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本骨科生物製剂市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本骨科生物製剂市场-细分：依产品

• 去矿骨基质
  • 概述
• 同种异体移植
  • 概述
• 骨形态发生蛋白
  • 概述
• 黏液补充产品
  • 概述
• 合成骨替代品
  • 概述
• 其他的

第七章：日本骨科生物製剂市场-细分：依类型

• 膝盖
  • 概述
• 踝
  • 概述
• 时髦的
  • 概述
• 腕部和肩部
  • 概述
• 脊椎
  • 概述
• 其他的

第 8 章：日本骨科生物製剂市场 - 细分：按应用

• 骨关节炎和退化性关节炎
  • 概述
• 脊椎融合
  • 概述
• 骨折恢復
  • 概述
• 软组织损伤
  • 概述
• 颚面和牙科应用
  • 概述

第九章：日本骨科生物製剂市场-细分：按最终用户

• 医院及门诊中心
  • 概述
• 研究与学术机构
  • 概述
• 牙科诊所和设施
  • 概述
• 骨科诊所
  • 概述

第 10 章：日本骨科生物製品市场 - 竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第 11 章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 12 章：日本骨科生物製剂市场 - 产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 13 章：附录

Japan orthobiologics market size reached USD 283.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 508.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The growing aging population, who are prone to orthopedic conditions such as osteoarthritis and fracture, on account of several factors, like sedentary lifestyles and obesity, is primarily driving the market.

Orthobiologics is a field of medicine that focuses on using natural substances and biological materials to enhance the body's own healing processes, particularly in orthopedic and musculoskeletal conditions. These therapies aim to stimulate tissue repair and regeneration, reducing the need for more invasive surgical interventions and potentially improving patient outcomes. Common orthobiologics include platelet-rich plasma (PRP), which involves concentrating and injecting a patient's own platelets to promote tissue healing, and stem cell therapy, which utilizes a patient's own stem cells or those from a donor to encourage tissue regeneration. Additionally, there are products like bone grafts and synthetic materials that mimic the properties of natural bone to support fracture healing and spinal fusion. Orthobiologics represent a promising area of research and treatment in orthopedics, with the potential to accelerate recovery, reduce pain, and improve overall function in patients with various musculoskeletal conditions, such as arthritis, tendon injuries, and bone fractures.

Japan Orthobiologics Market Trends:

The orthobiologics market in Japan is experiencing robust growth, primarily driven by a confluence of factors that underscore its promising future. Firstly, an aging population has significantly contributed to the market's expansion. As individuals age, the incidence of musculoskeletal disorders such as osteoarthritis and fractures increases, necessitating orthobiologic treatments that facilitate tissue regeneration and repair. Consequently, the rising geriatric demographic acts as a substantial driving force for the market's growth. Furthermore, technological advancements have played a pivotal role in propelling the orthobiologics market forward. Innovations in biotechnology and regenerative medicine have led to the development of more sophisticated and effective orthobiologic products. This includes the emergence of stem cell therapies, platelet-rich plasma (PRP) treatments, and growth factor-based solutions, all of which offer improved patient outcomes, driving demand for these cutting-edge therapies. Additionally, the emerging application of minimally invasive procedures that offer quicker recovery times, reduced pain, and fewer complications is expected to drive the orthobiologics market in Japan during the forecast period.

Japan Orthobiologics Market Segmentation:

Product Insights:

• Demineralized Bone Matrix
• Allograft
• Bone Morphogenetic Protein
• Viscosupplementation Products
• Synthetic Bone Substitutes
• Others

Type Insights:

• Knee
• Ankle
• Hip
• Wrist and Shoulder
• Spine
• Others

Application Insights:

• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial and Dental Applications

End User Insights:

• Hospitals and Ambulatory Centers
• Research and Academic Institutes
• Dental Clinics and Facilities
• Orthopedic Clinics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan orthobiologics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan orthobiologics market?
• What is the breakup of the Japan orthobiologics market on the basis of product?
• What is the breakup of the Japan orthobiologics market on the basis of type?
• What is the breakup of the Japan orthobiologics market on the basis of application?
• What is the breakup of the Japan orthobiologics market on the basis of end user?
• What are the various stages in the value chain of the Japan orthobiologics market?
• What are the key driving factors and challenges in the Japan orthobiologics?
• What is the structure of the Japan orthobiologics market and who are the key players?
• What is the degree of competition in the Japan orthobiologics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Orthobiologics Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Orthobiologics Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Orthobiologics Market - Breakup by Product

• 6.1 Demineralized Bone Matrix
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Allograft
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Bone Morphogenetic Protein
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Viscosupplementation Products
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Synthetic Bone Substitutes
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Others
  • 6.6.1 Historical and Current Market Trends (2019-2024)
  • 6.6.2 Market Forecast (2025-2033)

7 Japan Orthobiologics Market - Breakup by Type

• 7.1 Knee
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Ankle
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Hip
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Wrist and Shoulder
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Spine
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2019-2024)
  • 7.5.3 Market Forecast (2025-2033)
• 7.6 Others
  • 7.6.1 Historical and Current Market Trends (2019-2024)
  • 7.6.2 Market Forecast (2025-2033)

8 Japan Orthobiologics Market - Breakup by Application

• 8.1 Osteoarthritis and Degenerative Arthritis
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Spinal Fusion
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Fracture Recovery
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Soft Tissue Injuries
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Maxillofacial and Dental Applications
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)

9 Japan Orthobiologics Market - Breakup by End User

• 9.1 Hospitals and Ambulatory Centers
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Research and Academic Institutes
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Dental Clinics and Facilities
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)
• 9.4 Orthopedic Clinics
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2019-2024)
  • 9.4.3 Market Forecast (2025-2033)

10 Japan Orthobiologics Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Orthobiologics Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix